Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Peng T"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 22
Tytuł:
Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China.
Autorzy:
Qi LN; Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Li LQ; Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Chen YY; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Chen ZH; Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Bai T; Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Xiang BD; Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Qin X; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Xiao KY; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Peng MH; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Liu ZM; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Liu TW; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Qin X; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Li S; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Han ZG; China National Human Genome Center at Shanghai, Shanghai, China.
Mo ZN; Department of Urology and Nephrology Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Santella RM; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, United States of America.
Winkler CA; Laboratory of Genomic Diversity, National Cancer Institute, NIH, Frederick, Maryland, United States of America.
O'Brien SJ; Laboratory of Genomic Diversity, National Cancer Institute, NIH, Frederick, Maryland, United States of America.
Peng T; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China ; Laboratory of Genomic Diversity, National Cancer Institute, NIH, Frederick, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Dec 31; Vol. 8 (12), pp. e83465. Date of Electronic Publication: 2013 Dec 31 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosome Aberrations*
Aflatoxin B1/*toxicity
Aldehyde Reductase/*genetics
Carcinoma, Hepatocellular/*etiology
Carcinoma, Hepatocellular/*genetics
Hepatitis B virus/*pathogenicity
Liver Neoplasms/*etiology
Liver Neoplasms/*genetics
Adult ; Aged ; Aldehyde Reductase/metabolism ; Aldo-Keto Reductases ; Carcinoma, Hepatocellular/metabolism ; China ; Comparative Genomic Hybridization ; Disease-Free Survival ; Female ; Gene Dosage ; Hepatitis B, Chronic/complications ; Humans ; Liver Neoplasms/metabolism ; Male ; Middle Aged ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism ; Proteomics ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA, Neoplasm/genetics ; RNA, Neoplasm/metabolism ; Risk ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Autorzy:
Qi LN; Department of Hepatobiliary Surgery, Tumor Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Bai T
Chen ZS
Wu FX
Chen YY
De Xiang B
Peng T
Han ZG
Li LQ
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2015 Mar; Vol. 35 (3), pp. 999-1009. Date of Electronic Publication: 2014 Jan 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Aflatoxin B1/*toxicity
Carcinoma, Hepatocellular/*genetics
Genes, p53/*drug effects
Hepatitis B, Chronic/*complications
Liver Neoplasms/*genetics
Neoplasm Recurrence, Local/*genetics
Adult ; Carcinogenesis ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/virology ; Case-Control Studies ; Female ; Humans ; Liver Neoplasms/metabolism ; Liver Neoplasms/virology ; Male ; Middle Aged ; Mutation ; Prospective Studies ; Tumor Suppressor Protein p53/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.
Autorzy:
Han C; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Liao X; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Qin W; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Yu L; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Liu X; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Chen G; Department of Pathology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Liu Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Lu S; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Chen Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Su H; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Zhu G; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Lu Z; Department of Pathology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Liu Z; Department of General Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Qin X; Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Gui Y; Department of Clinical laboratory center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Mo Z; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Li L; Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Peng T; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Aug 09; Vol. 6, pp. 31237. Date of Electronic Publication: 2016 Aug 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular/*genetics
Cyclin-Dependent Kinase Inhibitor p21/*genetics
ErbB Receptors/*genetics
Hepatitis B/*complications
Liver Neoplasms/*genetics
Microfilament Proteins/*genetics
Nerve Tissue Proteins/*genetics
Nuclear Proteins/*genetics
Adult ; Biomarkers, Tumor/metabolism ; Carcinoma, Hepatocellular/virology ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Variation ; Genome-Wide Association Study ; Genotype ; Haplotypes ; Hepatitis B virus ; Humans ; Kaplan-Meier Estimate ; Linkage Disequilibrium ; Liver Neoplasms/virology ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Principal Component Analysis ; Quality Control ; RNA, Messenger/metabolism ; Treatment Outcome ; Tumor Suppressor Protein p53
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma.
Autorzy:
Yin F; Medical Scientific Research Centre, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.
Shu L; The First Affiliated Hospital, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.
Liu X; Centre for Translational Medicine, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.
Li T; Medical Scientific Research Centre, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.
Peng T; The First Affiliated Hospital, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.
Nan Y; School of Public Health, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.
Li S; School of Public Health, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China.
Zeng X; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China. .; School of Public Health, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China. .
Qiu X; School of Public Health, Guangxi Medical University, 22 Shuangyong Rd, Nanning, Guangxi, 530021, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2016 Aug 27; Vol. 35 (1), pp. 127. Date of Electronic Publication: 2016 Aug 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*genetics
Carcinoma, Hepatocellular/*genetics
Genetic Association Studies/*methods
Liver Neoplasms/*genetics
Oligonucleotide Array Sequence Analysis/*methods
Disease Progression ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Predisposition to Disease ; Humans ; Male ; Prognosis ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
Autorzy:
Yu T; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Han C; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Zhu G; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Liao X; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Qin W; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Yang C; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Liu Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Su H; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Liu X; Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China.
Yu L; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, Henan, China.
Liu Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Lu S; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Chen Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Liang Y; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Huang J; Department of Hepatobiliary Surgery, the Third Affiliated Hospital of Guangxi Medical University, Nanning, 530031, Guangxi, China.
Qin X; Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Gui Y; Department of Clinical Laboratory Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Li J; Medical Scientific Research Center, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Peng T; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2017 Jul; Vol. 6 (7), pp. 1587-1600. Date of Electronic Publication: 2017 May 31.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B virus*
Carcinoma, Hepatocellular/*etiology
Carcinoma, Hepatocellular/*mortality
Hepatitis B, Chronic/*complications
Liver Neoplasms/*etiology
Liver Neoplasms/*mortality
Receptors, Notch/*genetics
Adult ; Aftercare ; Aged ; Alleles ; Biomarkers, Tumor ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/surgery ; Disease Susceptibility ; Female ; Gene Expression ; Genotype ; Haplotypes ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/virology ; Humans ; Kaplan-Meier Estimate ; Linkage Disequilibrium ; Liver Neoplasms/pathology ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Staging ; Polymorphism, Single Nucleotide ; Prognosis ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Autorzy:
Yang CK; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Wang XK; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Liao XW; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Han CY; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Yu TD; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Qin W; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Zhu GZ; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Su H; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Yu L; Department of Hepatobiliary and Pancreatic Surgery, The first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Liu XG; Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, China.
Lu SC; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Chen ZW; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Liu Z; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Huang KT; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Liu ZT; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Liang Y; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Huang JL; Department of Hepatobiliary Surgery, Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Xiao KY; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Peng MH; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Winkle CA; Laboratory of Genomic Diversity, National Cancer Institute, NIH, Frederick, MD, United States of America.
O'Brien SJ; Laboratory of Genomic Diversity, National Cancer Institute, NIH, Frederick, MD, United States of America.
Peng T; Department of Hepatobiliary Surgery, The first Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Aug 08; Vol. 12 (8), pp. e0182208. Date of Electronic Publication: 2017 Aug 08 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*enzymology
Isoenzymes/*metabolism
Liver Neoplasms/*enzymology
Retinal Dehydrogenase/*metabolism
Aldehyde Dehydrogenase 1 Family ; Biomarkers, Tumor/metabolism ; Carcinoma, Hepatocellular/complications ; Datasets as Topic ; Disease-Free Survival ; Gene Expression Regulation, Neoplastic/physiology ; Hepatitis B/complications ; Hepatitis B/enzymology ; Hepatitis B virus ; Humans ; Liver Neoplasms/complications ; Logistic Models ; Prognosis ; RNA, Messenger/metabolism ; Recurrence ; Software
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma.
Autorzy:
Wang X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Yang C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Liao X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Han C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Yu T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Huang K; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Yu L; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, 450000, China.
Qin W; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Zhu G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Su H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Liu X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.; Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, 524001, China.
Ye X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Chen B; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Peng M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, 530021, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2017 Nov; Vol. 6 (11), pp. 2660-2672. Date of Electronic Publication: 2017 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*genetics
Mitochondrial Proteins/*genetics
Nod2 Signaling Adaptor Protein/*genetics
RNA, Messenger/*metabolism
Biomarkers, Tumor/genetics ; Databases, Genetic ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.
Autorzy:
Wang X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Yu T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Liao X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Yang C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Han C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Zhu G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Huang K; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Yu L; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province 450000, China.
Qin W; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Su H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Liu X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.; Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province 524001, China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Province, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2018 Apr; Vol. 7 (4), pp. 966-980. Date of Electronic Publication: 2018 Feb 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular/*genetics
Carcinoma, Hepatocellular/*mortality
Cytochrome P-450 Enzyme System/*genetics
Liver Neoplasms/*genetics
Liver Neoplasms/*mortality
Adult ; Aged ; Carcinoma, Hepatocellular/diagnosis ; Computational Biology/methods ; Databases, Genetic ; Female ; Gene Expression Regulation, Neoplastic ; Gene Ontology ; Gene Regulatory Networks ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/diagnosis ; Male ; Middle Aged ; Molecular Sequence Annotation ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma.
Autorzy:
Chen K; Hepatobiliary Surgery Institute, Southwest Hospital, Army Medical University, China.; Department Hepatobiliary Surgery Institute, Chengdu Fifth People's Hospital, China.
Li Z; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Zhang M; Department Rheumatology of Integrated Traditional Chinese and Western Medicine, Central Theater Command General Hospital of PLA, China.
Wang B; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Yangtze University, Jingzhou, China.
Shen Y; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Zhang J; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Ye J; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Liu Y; Department Hepatobiliary Surgery Institute, Chengdu Fifth People's Hospital, China.
Tang D; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Peng M; Hepatobiliary Surgery & Carson International Cancer Shenzhen University General Hospital & Shenzhen University Clinical Medical Academy Center, Shenzhen University, China.
Ma D; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Xiao Z; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Zhang Y; Hepatobiliary Surgery Institute, Southwest Hospital, Army Medical University, China.
Jin W; Department General Surgery, Central Theater Command General Hospital of PLA, China.
Li X; Hepatobiliary Surgery Institute, Southwest Hospital, Army Medical University, China.; Hepatobiliary Surgery & Carson International Cancer Shenzhen University General Hospital & Shenzhen University Clinical Medical Academy Center, Shenzhen University, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2020 Oct 05; Vol. 2020, pp. 1964219. Date of Electronic Publication: 2020 Oct 05 (Print Publication: 2020).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*genetics
Cell Adhesion Molecules/*genetics
Epithelial-Mesenchymal Transition/*genetics
Liver Cirrhosis/*genetics
Liver Neoplasms/*genetics
MicroRNAs/*genetics
Neoplasm Metastasis/*genetics
Animals ; Carcinogenesis/genetics ; Carcinogenesis/pathology ; Carcinoma, Hepatocellular/pathology ; Cell Line ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Disease Progression ; Down-Regulation/genetics ; Female ; Gene Expression Regulation, Neoplastic/genetics ; HEK293 Cells ; Hep G2 Cells ; Humans ; Liver Cirrhosis/pathology ; Liver Neoplasms/pathology ; Male ; Mice ; Mice, Nude ; Middle Aged ; Neoplasm Metastasis/pathology ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A 2-Benzylmalonate Derivative as STAT3 Inhibitor Suppresses Tumor Growth in Hepatocellular Carcinoma by Upregulating β-TrCP E3 Ubiquitin Ligase.
Autorzy:
Peng T; Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Wonganan O; Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.
Zhang Z; School of Chemistry Engineering, Sichuan University, Chengdu 610041, China.
Yu J; Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Xi R; Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Cao Y; Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Suksamrarn A; Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Ramkhamhaeng University, Bangkok 10240, Thailand.
Zhang G; Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.
Wang F; Center for Natural Products Research, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.; Xiongan Institute of Innovation, Chinese Academy of Sciences, Hebei 071700, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 25; Vol. 22 (7). Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*metabolism
Liver Neoplasms/*metabolism
Malonates/*pharmacology
STAT3 Transcription Factor/*metabolism
Ubiquitin-Protein Ligases/*metabolism
beta-Transducin Repeat-Containing Proteins/*metabolism
Animals ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Survival/drug effects ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Hep G2 Cells ; Humans ; Inhibitory Concentration 50 ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Invasiveness ; Neoplasm Transplantation ; Phosphorylation ; Recombinant Proteins/chemistry ; Response Elements ; Transducin ; Up-Regulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma.
Autorzy:
Wang JY; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Shuang Yong Road 6#, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.; Department of General Surgery, Shenzhen Children's Hospital, Yi Tian Road 7019#, Shenzhen, 518026, Guangdong Province, People's Republic of China.
Wang XK; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Shuang Yong Road 6#, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Zhu GZ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Shuang Yong Road 6#, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Shuang Yong Road 6#, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Yao J; Department of Gastroenterology, Jinan University of Second Clinical Medical Sciences, Shenzhen Municipal People's Hospital, Dong Men Bei Road 1017#, Shenzhen, 518020, Guangdong Province, People's Republic of China. yj_.
Ma XP; Department of General Surgery, Shenzhen Children's Hospital, Yi Tian Road 7019#, Shenzhen, 518026, Guangdong Province, People's Republic of China. .
Wang B; Department of General Surgery, Shenzhen Children's Hospital, Yi Tian Road 7019#, Shenzhen, 518026, Guangdong Province, People's Republic of China. .
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Shuang Yong Road 6#, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Apr 26; Vol. 21 (1), pp. 462. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*genetics
Glypicans/*genetics
Liver Neoplasms/*genetics
RNA, Messenger/*metabolism
Algorithms ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/mortality ; Computational Biology ; Confidence Intervals ; Databases, Genetic ; Gene Expression ; Gene Expression Profiling/methods ; Glypicans/metabolism ; Humans ; Kaplan-Meier Estimate ; Liver/metabolism ; Liver Neoplasms/metabolism ; Liver Neoplasms/mortality ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models.
Autorzy:
He Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Liang T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Mo S; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Chen Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Zhao S; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Yan L; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Wang X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Su H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Zhu G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Han C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Province, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2021 May 21; Vol. 21 (1), pp. 230. Date of Electronic Publication: 2021 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/surgery
Aged ; Hepatectomy ; Humans ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma.
Autorzy:
Wei ZL; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Lan CL; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Huang HS; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Liao XW; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Mo ST; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Wei YG; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, People's Republic of China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2022 Feb 22; Vol. 22 (1), pp. 77. Date of Electronic Publication: 2022 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lateral Flow Immunoassay Based on Time-Resolved Fluorescence Microspheres for Rapid and Quantitative Screening CA199 in Human Serum.
Autorzy:
Jiao X; College of Life Sciences, China Jiliang University, Hangzhou 310018, China.; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Peng T; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Liang Z; College of Life Sciences, China Jiliang University, Hangzhou 310018, China.; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Hu Y; College of Life Sciences, China Jiliang University, Hangzhou 310018, China.; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Meng B; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Zhao Y; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Xie J; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Gong X; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Jiang Y; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Fang X; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Yu X; College of Life Sciences, China Jiliang University, Hangzhou 310018, China.
Dai X; Center for Advanced Measurement Science, National Institute of Metrology, Beijing 100029, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 01; Vol. 23 (17). Date of Electronic Publication: 2022 Sep 01.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*
Metal Nanoparticles*
Biomarkers, Tumor ; Gold ; Humans ; Immunoassay ; Limit of Detection ; Microspheres
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
Autorzy:
Qi LN; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Ma L; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Wu FX; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Chen YY; Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Xu JX; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Peng YC; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Chen ZS; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Gong WF; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yang CL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Wei HW; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Qin SL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Shang JJ; Jiangsu Key Laboratory for Microbes and Functional Genomics, College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China.
Wang QY; Department of Biochemistry and Molecular Biology, Guangxi Medical University, Nanning, Guangxi, China.
Yu HP; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.
Peng T; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Huang YW; Department of Hepatobiliary Surgery, Chongzuo People's Hospital, Chongzuo, Guangxi, China.
Ling YC; Department of Surgery, Fusui County People's Hospital of Guangxi, Chongzuo, Guangxi, China.
Tang WZ; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.; Department of Colorectal & Anal Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xiang BD; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Li LQ; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.; Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning, Guangxi, China.; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning, Guangxi, China.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Oct; Vol. 42 (10), pp. 2283-2298. Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/pathology
Hepatectomy/methods ; Humans ; Neoplasm Recurrence, Local/pathology ; Nomograms ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CT-guided percutaneous microwave ablation for pulmonary metastases from colorectal cancer: Prognosis analyses based on the origin of the primary tumor.
Autorzy:
Huang Y; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Wu K; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Liu Y; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Li D; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Lai H; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Peng T; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Wan Y; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zhang B; Department of Interventional Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Pokaż więcej
Źródło:
Journal of X-ray science and technology [J Xray Sci Technol] 2023; Vol. 31 (5), pp. 1001-1011.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/pathology
Colorectal Neoplasms*/surgery
Lung Neoplasms*/diagnostic imaging
Colonic Neoplasms*
Rectal Neoplasms*
Liver Neoplasms*
Humans ; Microwaves/therapeutic use ; Prognosis ; Tomography, X-Ray Computed ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration.
Autorzy:
Nong JS; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Liu JQ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Luo JZ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Huang JM; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Xie HX; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Yang KJ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Wang J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Ye XP; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.; Key Laboratory of Early Prevention & Treatment for Regional High Frequency Tumor, Ministry of Education, Guangxi Medical University, Nanning, People's Republic of China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 May; Vol. 12 (9), pp. 10990-11009. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/diagnosis
Liver Neoplasms*/genetics
Nuclear Pore Complex Proteins*/genetics
Humans ; Biomarkers ; China ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery.
Autorzy:
Long L; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510450, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Xiong W; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510450, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528437, China.
Lin F; Department of Kidney Transplantation, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Hou J; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Chen G; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510450, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528437, China.
Peng T; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528437, China.
He Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528437, China.
Wang R; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528437, China.
Xu Q; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510450, China. .
Huang Y; Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, 510450, China. .; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. .; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, 528437, China. .; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Shanghai, 201203, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 May 10; Vol. 42 (1), pp. 117. Date of Electronic Publication: 2023 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Neoplasms*/drug therapy
Colorectal Neoplasms*/drug therapy
Humans ; Animals ; Mice ; Lactic Acid ; CD8-Positive T-Lymphocytes ; Epithelial-Mesenchymal Transition ; Hyaluronic Acid ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
Autorzy:
Wei Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Lan C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Yang C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Liao X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Huang X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Xie H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Zhu G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China.; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. .; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, 530021, Nanning, People's Republic of China. .; Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 04; Vol. 13 (1), pp. 14519. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/therapy
Humans ; Prognosis ; China ; Nomograms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.
Autorzy:
Zeng Z; Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Liao X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Huang K; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Han C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Qin W; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Su H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Ye X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Yang C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Zhou X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Wei Y; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Mo S; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Liu J; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Lan C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Huang X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Huang Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Peng K; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Gao Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China.
Peng T; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China. .; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China. .
Zhu G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China. .; Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 Oct 13; Vol. 21 (1), pp. 322. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/genetics
Liver Neoplasms*/surgery
Hepatitis B*/complications
Humans ; Hepatitis B virus/genetics ; Dyneins/genetics ; Case-Control Studies ; Cohort Studies ; Hepatectomy/adverse effects ; Follow-Up Studies ; Genetic Predisposition to Disease ; Polymorphism, Single Nucleotide ; China/epidemiology ; Genotype ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 22

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies